Jushi Holdings (JUSHF) Non-Current Assets (2021 - 2026)

Jushi Holdings' (JUSHF) quarterly Non-Current Assets came in at $350.5 million in Q1 2026, down 3.98% year-on-year from $365.0 million in Q1 2025, and down 1.01% on a QoQ basis from $354.0 million in Q4 2025.

Jushi Holdings (JUSHF) Non-Current Assets (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of Non-Current Assets data on file, last reported at $350.5 million in Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 3.98% year-over-year to $350.5 million in Q1 2026; TTM through Mar 2026 was $350.5 million, a 3.98% decrease from a year earlier, with the FY2025 full-year figure at $354.0 million, down 3.84% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $350.5 million, down from $354.0 million in the prior quarter.
  • Over the last five years, Non-Current Assets for JUSHF reached as high as $613.5 million in Q2 2022 and fell as low as $350.5 million in Q1 2026.
  • Historically, Non-Current Assets has averaged $418.4 million across 5 years, with a median of $374.8 million in 2024.
  • Across the five-year window, Non-Current Assets plunged 32.97% in 2023 and increased 0.64% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $459.3 million in 2022, then slipped by 16.88% to $381.8 million in 2023, then fell by 3.56% to $368.2 million in 2024, then slipped by 3.84% to $354.0 million in 2025, then declined by 1.01% to $350.5 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $350.5 million in Q1 2026, $354.0 million in Q4 2025, and $363.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Jushi Holdings 81.25 Mn 41.54 Mn 29.88 Mn 350.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 350.46 Mn
Dec 31, 2025 354.03 Mn
Sep 30, 2025 363.10 Mn
Jun 30, 2025 368.14 Mn
Mar 31, 2025 364.97 Mn
Dec 31, 2024 368.17 Mn
Sep 30, 2024 360.79 Mn
Jun 30, 2024 366.45 Mn
Mar 31, 2024 374.85 Mn
Dec 31, 2023 381.76 Mn
Sep 30, 2023 400.41 Mn
Jun 30, 2023 411.20 Mn
Mar 31, 2023 454.94 Mn
Dec 31, 2022 459.29 Mn
Sep 30, 2022 584.54 Mn
Jun 30, 2022 613.49 Mn
Mar 31, 2022 536.92 Mn
Dec 31, 2021 497.69 Mn